Nvidia's $50M Leap into AI-Driven Drug Discovery
In this episode, we delve into Nvidia's significant investment of $50 million in Recursion, an AI drug discovery firm. We explore the potential impact of this collaboration on the future of pharmaceut...
2 Jan 20249min
Regulatory Gaze: FTC Probes OpenAI for ChatGPT's Reputational Risks
In this episode, we delve into the FTC's investigation of OpenAI, focusing on the reputational harm caused by ChatGPT. We explore the regulatory challenges and ethical considerations surrounding AI te...
2 Jan 202410min
Stability AI: Overcoming a $500M Setback with Innovative AI
In this episode, we examine Stability AI's challenging yet innovative phase, marked by a $500 million mistake and the launch of a novel AI model that transforms doodles into detailed images. We discus...
2 Jan 202410min
X.AI: Musk's New Quest to Decode the Universe
In this episode, we delve into Elon Musk's latest venture, X.AI, aimed at understanding the nature of the universe. We discuss the involvement of top talent from DeepMind and OpenAI and what this coll...
2 Jan 20249min
Shopify's AI Store Manager: Revolutionizing E-Commerce
In this episode, we explore Shopify's innovative move to let AI manage online stores, offering automated, data-driven decision making for retailers. We discuss the implications for efficiency, persona...
2 Jan 20246min
Google's Quantum Supremacy: A New Era for AI
In this episode, we delve into Google's latest claim of achieving quantum supremacy and its profound impact on the field of AI. We explore the possibilities and challenges this breakthrough presents f...
2 Jan 202414min
GPT-4 Secrets Uncovered: Leaked Cost, Weights, and 1.8T Parameters
In this episode, we dive into the recent leak surrounding GPT-4, revealing its cost, weights, and the staggering 1.8 trillion parameters. We explore the implications of these revelations for the AI in...
2 Jan 202410min
Claude 2 Unveiled: Anthropic's $4.1B Bid to Outshine ChatGPT-4
In this episode, we dive into the launch of Claude 2 by Anthropic, a formidable $4.1 billion contender against OpenAI's ChatGPT-4. We explore the advancements and features that set Claude 2 apart in t...
2 Jan 202413min
